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Alok Sharma*, Geetanjali Paliwal, Nisha Upadhyay and Archana TiwariThe Editors are retracting this article [1] due to overlap
with previous publications, most notably [2, 3]. We
apologise for any inconvenience caused. We have been
unable to contact the authors regarding the retraction of
their article.
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